10 Jan 2022
Our lead drug EP395 is currently in Phase 1 clinical trial and we wish to expand our platform in discovery of novel potential candidate drugs. Thus, we are looking for a technician to join us on this exciting journey.
EpiEndo is in part a virtual company, with offices and a laboratory in Iceland, but with the several team members working remotely across Europe. However, we meet regularly face to face and we have a great team working closely together despite long distance!
Job description
As a technician you will:
Desired and Required Qualifications
Education
Experience
Preferred Skills and Competencies
Organizational skills
About EpiEndo
EpiEndo is a clinical-stage biopharmaceutical company with a unique approach to inflammatory disorders that focuses on enhancement of epithelial barrier integrity as a causal pathophysiological factor underlying the etiology of several major diseases. Epithelial cells are a key component of the barrier that makes up human skin and lung tissue, as well as the intestinal tract and genitalia. Compromised integrity of this barrier is implicated in the progression and non-resolution of inflammation.
EpiEndo is developing a proprietary portfolio of orally available drug candidates with promise as first-in-class disease-modifying therapeutics, to address the huge global burden of chronic respiratory diseases and other significant unmet medical needs.
EpiEndo’s lead drug candidate, EP395, aims to be the first on-market oral, disease modifying, barrier strengthening and anti-inflammatory drug for COPD.
For more information, please visit www.epiendo.com
Application & Contact
Please send your CV and cover letter to jobs@epiendo.com.
Should you have any questions, please email HR@epiendo.com or call +354 454 0090 and ask for Jennifer Kricker (Preclinical Research Director).
Closing day for applications is 1 February, 2022.
No agencies or recruiters please.